Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study

J Chemother. 2009 Jun;21(3):317-21. doi: 10.1179/joc.2009.21.3.317.

Abstract

A cohort study of patients (pts) presenting with symptoms of chronic prostatitis over 2 years was performed. Appropriate antimicrobials were administered to confirmed cases of chronic bacterial prostatitis (CBP) after a Stamey-meares (S-M) test for a period of 6 weeks and the test was repeated 1 and 6 months post therapy completion. 145 male patients presented for evaluation. the most prevalent symptoms included dysuria (68%), frequency (38%), and pain which was present in 50%. S-M testing was performed in 69% and expressed prostatic specimen was collected in 53.8%. the diagnosis of CBP was established in 26.9% of the total cohort. Escherichia coli (28.2%) and Enterococcus spp (23.1%) were the most frequently implicated pathogens and ciprofloxacin the most commonly prescribed antimicrobial. A 12-month follow-up was completed in 87% of the pts and 35.3% relapsed a mean of 4.75 months after the initial treatment.

MeSH terms

  • Adult
  • Anti-Infective Agents / therapeutic use*
  • Ciprofloxacin / therapeutic use
  • Cohort Studies
  • Fluoroquinolones / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prostatitis / diagnosis
  • Prostatitis / drug therapy*

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Ciprofloxacin